director security architect Brentford, England
Job description
Posted Date: Jul 14 2023
As Senior Director, Security Architecture, the candidate will have end-to-end responsibility for GSK’s security architecture reporting to the Deputy CISO, Cyber Security Strategy and Solutions.
To achieve this, the candidate will lead a global team of security architects responsible for evaluating and recommending security solutions in alignment to our cyber strategy including cloud, data, and technology blueprints.
The cyber security solutions architected by this team will ensure the security of the global network and therefore, this candidate must be a senior technology leader with proven experience architecting secure by design solutions. The candidate will interact, collaborate, and form alignment with other Cyber Security Office (CSO) teams as well as affiliated GSK tech professionals including the Enterprise Architecture Team.
This role will engage with senior contacts in tech and across the business for the identification of information security needs and will ensure that appropriate controls are designed into our platforms, new products, and capabilities.
Responsibilities:
Provide leadership, direction, and development of a team of multi-disciplined security architects, including varying levels of staff in a matrixed, virtual environment, sustaining team energy, wellbeing, and resilience
End to end ownership of security architecture and secure by design principals
Integrate a deep understanding of business changes on the horizon into security solutions which will require interaction with senior tech executives and stakeholders across the organization
Contribute to research in emerging cyber solutions and strategies
Evaluate and implement security controls to be used across our platforms and all layers of the application stack while maintaining alignment with GSK’s overall enterprise strategy and architecture
Support the development of reference architectures and associated reusable work products and assessment assets including detailed designs that provide deployable building blocks.
Responsibility for the identification of security design gaps in existing or new systems and recommend mitigations.
Play a key role as part of the Enterprise Architecture Group who drive an integrated architectural plan across the company.
Partner with security engineering and platform support engineering to set the course for secure development practices for existing and future security solutions.
Basic qualifications:
The candidate must have extensive and proven experience in the architecture of secure solutions
Knowledge of legal and/or regulatory matters in the context of enterprise security
10+ years in architecture security
Understanding of DevOps/DevSecOps
Ability to work in a complex and fast paced environment
Ability to write, develop, and maintain technical documentation, including reference architecture and implementation plans
Experience in the implementation of cyber solutions and standard methodologies
Extensive know-how of security technology including, but not limited to, authentication and authorization, security protocols, cloud security, AI/ML
Deep understanding of enterprise architecture and security frameworks like TOGAF, NIST, CIS, etc.
Analyse industry, market, and technology trends and forecast impacts on the enterprise cybersecurity strategy
Knowledge in the business principles of secure system design and experience of modern design techniques including simulations
Strong written and verbal communications skills and proven experience in conveying direction effectively and clearly to both highly technical and non-technical audiences, including senior leadership
Ability to work across boundaries, both organisationally and geographically
Computer Science Degree
CISSP
Preferred Qualifications
Advanced degree in Computer Science
Experience in global pharma and/or a life sciences company
CISM, CPP preferred
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.
As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class*(*US only).
We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [email protected] or 0808 234 4391. Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels
As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.
We’re moving towards a more sustainable future with our new headquarters. With better public transport links and proximity to world-class science and technology institutions, we’re excited for our move to the vicinity of Earnshaw Street, London WC1A (“the New HQ”) by end H1 2024.
